AJANTA PHARMA
Back to Income Statement
|
AJANTA PHARMA Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹4,209 Cr | ₹3,743 Cr | ₹3,341 Cr | ₹2,890 Cr | ₹2,588 Cr |
What is the latest Revenue of AJANTA PHARMA ?
Year | Revenue |
---|---|
Mar2024 | ₹4,209 Cr |
Mar2023 | ₹3,743 Cr |
Mar2022 | ₹3,341 Cr |
Mar2021 | ₹2,890 Cr |
Mar2020 | ₹2,588 Cr |
How is Revenue of AJANTA PHARMA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹4,209 Cr | 12.45 | |
Mar2023 | ₹3,743 Cr | 12.02 | |
Mar2022 | ₹3,341 Cr | 15.62 | |
Mar2021 | ₹2,890 Cr | 11.66 | |
Mar2020 | ₹2,588 Cr | - |
Compare Revenue of peers of AJANTA PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AJANTA PHARMA | ₹35,053.2 Cr | -1.5% | -1.2% | 50.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹435,179.0 Cr | 0.4% | 0.8% | 45.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,995.0 Cr | -1.4% | 1.2% | 62% | Stock Analytics | |
CIPLA | ₹116,890.0 Cr | -1.5% | -5.1% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,993.0 Cr | -0.7% | -1.3% | 13.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,444.9 Cr | -0.5% | 3% | 54.1% | Stock Analytics |
AJANTA PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AJANTA PHARMA | -1.5% |
-1.2% |
50.4% |
SENSEX | 0.5% |
3.3% |
17.6% |
You may also like the below Video Courses